<table border="1"><tr><th>Systematic Nomenclature (IUPAC)</th><td><ul><li>4-[2-[4-(6-fluorobenzo[ | d | ]isoxazol-3-yl)- | 1-piperidyl]ethyl]-3-methyl- | 2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one</li></ul></td></tr><tr><th>Identity information.</th><td><ul><li>CAS Registry | 106266-06-2 | ATC Code | N05 | AX08 | PubChem | 5073 | Drumbank | DB00734 | ChemSpider | 4895.</li></ul></td></tr><tr><th>Chemical properties.</th><td><ul><li>Chemical | C | 23 | H | 27 | F | N | 4 | O | 2 | Molecular mass | 410.485 g/mol | SMILES | eMolecules | &amp; | PubChem</li></ul></td></tr><tr><th>Pharmaceutical Information</th><td><ul><li>Biocompatibility | 70% (oral) | drug administration | administration in the liver (CYP2D6 is translated into 9-hydroxyrisperidone) | bioluminescence | 20 hours (on oral intake), 2.9 to 6 days (dose) | emissions | urine (70% (male), 4.3% (child), 7.4% (female)), urine (14%)</li></ul></td></tr><tr><th>Prescription Recommendations</th><td><ul><li>Pregnant Safety | B3 | (Australia) | C | (United States) | Legal Status | Prescription Requirement (S4) | (Australia) | POM | (United Kingdom) |  | -only | (United States) | Dosage Methods | Oral Injection (dosage form and liquid form), prescription</li></ul></td></tr></table>